This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Kirin Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Akihisa Mori: Innovator in Parkinson's Disease Treatment
Introduction
Akihisa Mori is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of Parkinson's disease. His innovative approach has led to the development of a therapeutic agent that offers hope to many patients.
Latest Patents
Mori holds a patent for a therapeutic agent for Parkinson's disease. This agent contains istradefylline as an effective ingredient and is characterized by its ability to exhibit a more pronounced shortening effect of the OFF time when administered to patients aged 65 or older compared to those younger than 65. This advancement is crucial in improving the quality of life for elderly patients suffering from this debilitating condition.
Career Highlights
Mori is associated with Kyowa Kirin Co., Ltd., a leading pharmaceutical company. His work at the company has been instrumental in advancing research and development in therapeutic solutions for neurological disorders. His dedication to improving patient outcomes is evident in his innovative contributions.
Collaborations
Mori has collaborated with notable colleagues, including Tomoyuki Kanda and Takanobu Nomura. Their combined expertise has fostered a productive environment for innovation and research in the field of medicine.
Conclusion
Akihisa Mori's work in developing a therapeutic agent for Parkinson's disease highlights his commitment to enhancing patient care. His contributions are paving the way for better treatment options for those affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile